ClinicalTrials.govpublic full text
Phase I Study to Determine the Optimal Human Challenge Dose for a Norovirus GII.4 Challenge Stock (CIN-1)
gastroenteritis norovirus, nov, cin-1, gii4. norovirus, challenge, fut-2 gene, hbga-blocking ab, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 906957
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.